Global Retirement Partners LLC Raises Position in Stryker Co. (NYSE:SYK)

Global Retirement Partners LLC raised its stake in Stryker Co. (NYSE:SYK) by 14.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,052 shares of the medical technology company’s stock after purchasing an additional 869 shares during the quarter. Global Retirement Partners LLC’s holdings in Stryker were worth $2,539,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of SYK. DSM Capital Partners LLC increased its position in shares of Stryker by 358.7% during the fourth quarter. DSM Capital Partners LLC now owns 3,289 shares of the medical technology company’s stock valued at $1,184,000 after acquiring an additional 2,572 shares during the last quarter. Atlas Legacy Advisors LLC purchased a new stake in shares of Stryker during the fourth quarter valued at approximately $777,000. Bank of Jackson Hole Trust purchased a new stake in shares of Stryker during the fourth quarter valued at approximately $645,000. Callahan Advisors LLC increased its position in shares of Stryker by 0.3% during the fourth quarter. Callahan Advisors LLC now owns 50,864 shares of the medical technology company’s stock valued at $18,313,000 after acquiring an additional 167 shares during the last quarter. Finally, Davidson Investment Advisors increased its position in shares of Stryker by 2.2% during the fourth quarter. Davidson Investment Advisors now owns 1,390 shares of the medical technology company’s stock valued at $500,000 after acquiring an additional 30 shares during the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 201,392 shares of Stryker stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the completion of the sale, the director now owns 3,642,075 shares of the company’s stock, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Allan C. Golston sold 2,458 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the sale, the director now owns 14,895 shares in the company, valued at $5,705,827.65. The trade was a 14.16 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by corporate insiders.

Stryker Price Performance

Stryker stock opened at $386.47 on Friday. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The business has a fifty day moving average price of $377.92 and a 200-day moving average price of $368.21. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The firm has a market capitalization of $147.47 billion, a P/E ratio of 49.80, a PEG ratio of 2.90 and a beta of 0.96.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter last year, the business earned $3.46 earnings per share. As a group, equities research analysts forecast that Stryker Co. will post 13.49 EPS for the current year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be paid a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 0.87%. The ex-dividend date is Monday, March 31st. Stryker’s dividend payout ratio is 43.30%.

Analyst Ratings Changes

A number of analysts recently commented on SYK shares. Morgan Stanley raised Stryker from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $370.00 to $445.00 in a research report on Monday, December 2nd. Robert W. Baird increased their price target on Stryker from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. StockNews.com downgraded Stryker from a “buy” rating to a “hold” rating in a research report on Thursday, January 30th. Canaccord Genuity Group raised their target price on Stryker from $420.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Finally, JPMorgan Chase & Co. raised their target price on Stryker from $420.00 to $445.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 29th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $420.68.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.